Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125371461 | 12537146 | 1 | I | 20151228 | 20160707 | 20160707 | PER | US-JAZZ-2015-US-022608 | JAZZ | 0.00 | F | Y | 0.00000 | 20160707 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125371461 | 12537146 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.5 G, BID | 21196 | 2.5 | G | ORAL SOLUTION | |||||||
| 125371461 | 12537146 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3.5 G, BID | 21196 | 3.5 | G | ORAL SOLUTION | |||||||
| 125371461 | 12537146 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4.5 G, BID | 21196 | 4.5 | G | ORAL SOLUTION | |||||||
| 125371461 | 12537146 | 4 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | 21196 | 3 | G | ORAL SOLUTION | |||||||
| 125371461 | 12537146 | 5 | C | TEMAZEPAM. | TEMAZEPAM | 1 | UNK | U | 0 | CAPSULE | |||||||||
| 125371461 | 12537146 | 6 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | UNK | U | 0 | TABLET | |||||||||
| 125371461 | 12537146 | 7 | C | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 1 | UNK | U | 0 | CAPSULE | |||||||||
| 125371461 | 12537146 | 8 | C | NUVIGIL | ARMODAFINIL | 1 | UNK | U | 0 | TABLET | |||||||||
| 125371461 | 12537146 | 9 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | UNK | U | 0 | CAPSULE | |||||||||
| 125371461 | 12537146 | 10 | C | HYDROXYZINE PAMOATE. | HYDROXYZINE PAMOATE | 1 | UNK | U | 0 | CAPSULE | |||||||||
| 125371461 | 12537146 | 11 | C | ACYCLOVIR. | ACYCLOVIR | 1 | UNK | U | 0 | CAPSULE | |||||||||
| 125371461 | 12537146 | 12 | C | ACETAMINOPHENHYDROCODONE BITARTRATE | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125371461 | 12537146 | 1 | Narcolepsy |
| 125371461 | 12537146 | 2 | Cataplexy |
| 125371461 | 12537146 | 5 | Product used for unknown indication |
| 125371461 | 12537146 | 6 | Product used for unknown indication |
| 125371461 | 12537146 | 7 | Product used for unknown indication |
| 125371461 | 12537146 | 8 | Product used for unknown indication |
| 125371461 | 12537146 | 9 | Product used for unknown indication |
| 125371461 | 12537146 | 10 | Product used for unknown indication |
| 125371461 | 12537146 | 11 | Product used for unknown indication |
| 125371461 | 12537146 | 12 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125371461 | 12537146 | Nasopharyngitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125371461 | 12537146 | 1 | 200505 | 2005 | 0 | |
| 125371461 | 12537146 | 2 | 2005 | 2005 | 0 | |
| 125371461 | 12537146 | 3 | 2005 | 200604 | 0 | |
| 125371461 | 12537146 | 4 | 201501 | 0 | ||
| 125371461 | 12537146 | 5 | 20150128 | 0 | ||
| 125371461 | 12537146 | 6 | 20150112 | 0 | ||
| 125371461 | 12537146 | 7 | 20150109 | 20150116 | 0 | |
| 125371461 | 12537146 | 8 | 20150101 | 0 | ||
| 125371461 | 12537146 | 9 | 20141101 | 0 | ||
| 125371461 | 12537146 | 10 | 20140101 | 0 | ||
| 125371461 | 12537146 | 11 | 20131201 | 0 | ||
| 125371461 | 12537146 | 12 | 20120101 | 0 |